Ellis G. Levine MD
Ellis G. Levine
MD
Education and Training:
- Fellowship, Medical Oncology, University of Minnesota (1984)
- Residency, University of Minnesota (1982)
- MD, Internal Medicine, University of Pittsburgh (1979)
Employment:
- Professor, Medicine, Roswell Park Comprehensive Cancer Center (2015-present)
- Professor of Oncology, Medicine, Roswell Park Cancer Institute (2010-present)
- Associate Professor of Medicine, Medicine, University at Buffalo, The State University of New York (1994-present)
- Acting Chairman, Division of Medicine, Medicine, Roswell Park Cancer Institute (2000–2002)
- Acting Chairperson, Departments of Solid Tumor Oncology and Investigational Therapeutics, Medicine, Roswell Park Cancer Institute (1997–1998)
- Assistant Professor of Medicine, Medicine, University at Buffalo, The State University of New York (1989–1994)
- Assistant Professor of Medicine, University of Minnesota (1985–1989)
- Instructor of Medicine, University of Minnesota (1984–1985)
Awards and Honors:
- NCI Cancer Trials Support Unit Certificate of Outstanding Achievement (2010)
- Buffalo Spree‘s Top WNY Physicians 2005-2010 (2010)
- Cambridge Who's Who in the Field of Research, Medicine, Healthcare (2009)
- Best Medical Oncology Teaching Attending Award, RPCI (2005)
- AcademicKeys Who's Who in Medical Sciences (2005)
Research Expertise:
- Bladder, Breast, Prostate, Testicular Cancers
- Novel Therapies for Breast and Urothelial Cancer
Grants and Sponsored Research:
- May 2014–February 2019
Network lead Academic Participating Site Grant
NCI
Role: Co-Principal Investigator
$362,780 - April 1993–March 2015
Cancer and Leukemia Group B: RPCI/SUNYAB
NIH
Role: Principal Investigator - May 2008–April 2014
Protocol review and monitoring
NCI
Role: Contributor
$4,168,904 - July 2006–June 2012
Vascular-Targeting Anti-Angiogenic Therapy of Human Breast Cancer
US Army
Role: Co-Investigator
$544,630 - August 2001–July 2004
Selenium and Vitamin E Chemoprevention Trial
Southwest Oncology Group
Role: Principal Investigator
$68,463 - June 1993–May 2004
Prostate Cancer Prevention Trial
Research Foundation of South Texas
Role: Principal Investigator
$52,787 - January 2006
Princess Margaret Hospital Phase II Consortium
Role: Principal Investigator
$8,000 - January 2003
Cancer and Leukemia Group B: Cancer Trials Support Unit
NCI
Role: Principal Investigator
$990,447 - October 1994
Cancer Control Clinical Trials Program
Role: Co-Principal Investigator
$1,395,980
Journal Articles:
- Hussain M, Daignault S, Agarwal N, Grivas PD, Siefker-Radtke AO, Puzanov I, Macvicar GR, Levine EG, Srinivas S, Twardowski P, Eisenberger MA, Quinn DI, Vaishampayan UN, Yu EY, Dawsey S, Day KC, Day ML, Al-Hawary M, Smith DC. A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma. Cancer. 2014.
- Lagman RA, Yoo GJ, Levine EG, Donnell KA, Lim HR. "Leaving it to God" religion and spirituality among Filipina immigrant breast cancer survivors. J Relig Health. 2014; 53(2).
- Yoo GJ, Levine EG, Pasick R. Breast cancer and coping among women of color: a systematic review of the literature. Support Care Cancer. 2014; 22(3).
- Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Sircar K, Somer B, Wang J, Wilder RB, Dwyer MA, Kumar R. Kidney cancer, version 2.2014. J Natl Compr Canc Netw. 2014; 12(2).
- Rehman S, Crane A, Din R, Raza SJ, Shi Y, Wilding G, Levine EG, George S, Pili R, Trump DL, Guru KA. Understanding avoidance, refusal, and abandonment of chemotherapy before and after cystectomy for bladder cancer. Urology. 2013; 82(6).
- Lynn B, Yoo GJ, Levine EG. "Trust in the Lord": Religious and Spiritual Practices of African American Breast Cancer Survivors. J Relig Health. 2013.
- Ngamphaiboon N, O'Connor TL, Advani PP, Levine EG, Kossoff EB. Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis. Med Oncol. 2012; 29(3).
- Ademuyiwa FO, Bshara W, Attwood K, Morrison C, Edge SB, Karpf AR, James SA, Ambrosone CB, O'Connor TL, Levine EG, Miliotto A, Ritter E, Ritter G, Gnjatic S, Odunsi K. NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer. PLoS One. 2012; 7(6).
- Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Levine EG, Lin DW, Margolin KA, Michaelson MD, Olencki T, Pili R, Ratliff TW, Redman BG, Robertson CN, Ryan CJ, Sheinfeld J, Wang J, Wilder RB. Testicular cancer. J Natl Compr Canc Netw. 2012; 10(4).
- Yoo GJ, Levine EG, Aviv C, Ewing C, Au A. Older women, breast cancer, and social support. Support Care Cancer. 2010; 18(12).
- Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwartz LH, Sheinfeld J, Wang J. NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw. 2009; 7(6).
- Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL, Hudes GR, Jonasch E, Kessinger A, Kuzel TM, Lange PH, Levine EG, Margolin KA, Michaelson MD, Olencki T, Pili R, Redman BG, Robertson CN, Schwartz LH, Sheinfeld J, Wang J. NCCN clinical practice guidelines in oncology: testicular cancer. J Natl Compr Canc Netw. 2009; 7(6).
- Motzer RJ, Bolger GB, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Jonasch E, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pohar K, Redman BG, Robertson CN, Samlowski WE, Sheinfeld J. Kidney cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006; 4(10).
- Motzer RJ, Bolger GB, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Jonasch E, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pohar KS, Redman BG, Robertson CN, Samlowski WE, Sheinfeld J. Testicular cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006; 4(10).
- Motzer RJ, Bahnson RR, Boston B, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Redman BG, Richey S, Robertson CN, Samlowski WE, Sheinfeld J, Urban DA. Testicular cancer. Clinical practice guidelines. J Natl Compr Canc Netw. 2005; 3(1).
- Motzer RJ, Carducci MA, Fishman M, Hancock SL, Hauke RJ, Hudes GR, Kantoff P, Kuzel TM, Lange PH, Levine EG, Logothetis C, Margolin KA, Pili R, Pohar KS, Redman BG, Richey S, Robertson CN, Samlowski WE, Sheinfeld J, Urban DA. Kidney cancer. Clinical practice guidelines. J Natl Compr Canc Netw. 2005; 3(1).
- Halabi S, Small EJ, Kantoff PW, Kattan MW, Kaplan EB, Dawson NA, Levine EG, Blumenstein BA, Vogelzang NJ. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol. 2003; 21(7).
- Sabel MS, Levine EG, Hurd T, Schwartz GN, Zielinski R, Hohn D, Edge SB. Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition.. Am J Clin Oncol. 2001; 24(4).
- Bauer RL, Busch E, Levine E, Edge SB. Therapy for inflammatory breast cancer: impact of doxorubicin-based therapy.. Ann Surg Oncol. 1995; 2(4).
Professional Memberships:
- WNY Breast Resource Center Advisory Board (1997–present)
- Association of Subspecialty Professors (1994–present)
- American College of Physicians, Fellow; Fellow (1990–present)
- American Society of Clinical Oncology (1988–present)
- American Society of Hematology (1987–present)
- American Association for Cancer Research (1984–present)
- American Association for the Advancement of Science (1984–present)
Presentations:
- "Managing Treatment's Side Effects in Advanced Prostate Cancer" Internaitonal Symposium on Uro-Oncology, Roswell Park Cancer Institute (2012)
- "Breast Cancer - When to Treat and What to Use?" Pharmacy Oncology Symposium, Roswell Park Cancer Institute (2006)
- "Breast Cancer: Highlights from ASCO 2006" Roswell Park Cancer Institute, Roswell Park Cancer Institute (2006)
- "Drugs Commonly Used in Breast Cancer" Pharmacology Oncology Symposium, Roswell Park Cancer Institute (2004)
- "Breast Cancer - ASCO Update" Roswell Park Cancer Institute, Roswell Park Cancer Institute (2004)
- "Hot Topics at ASCO" Roswell Park Cancer Institute (2003)